The HICCC has awarded three new pilot grants to Columbia University faculty members whose research ideas are targeting accelerated solutions to combat COVID-19.
The Proteomics and Macromolecular Crystallography Shared Resource (PMCSR) provides researchers cutting-edge proteomic and structural biology technologies and analysis.
On Monday, March 2nd, the first confirmed COVID-19 patient in New York arrived at NewYork-Presbyterian Hospital/CUIMC. That afternoon, a team of oncology nurses and staff sprung to action.
With next-generation sequencing, it possible not only to look at individual genomes, but also to rapidly compare genetic sequences among multiple genomes.
Alison Schroeter is a clinical trials oncology nurse at the Herbert Irving Comprehensive Cancer Center (HICCC) and was redeployed to assist COVID-19 clinical trials at NewYork-Presbyterian Hospital.
The Single Cell Analysis shared resource provides researchers with experimental and comprehensive computational support for single-cell RNA-Sequencing and single-cell ATAC-Sequencing.
COE brings together a team of experienced researchers, clinicians, and community health educators with the mission of reducing the burden of cancer and cancer disparities.
Dr. Alexander Melamed, a member of the Cancer Population Science program at the HICCC, joined Columbia in July of 2019 as assistant professor of obstetrics and gynecology at Columbia’s VP&S.
Aaron Garcia, a graduate student at Columbia University’s School of Nursing, is currently working as a nurse technician at NewYork-Presbyterian Hospital on the COVID-19 front lines.
